The MRL confirms the safety of Benchmark’s sea lice solution for consumers and represents a significant milestone in the regulatory approval process towards the anticipated commercial launch of BMK08 and CleanTreat in Norway, said the statement.
The commercial launch remains subject to the grant of a Marketing Authorisation in Norway.
Sea lice are among the biggest biological challenge in salmon farming, said Benchmark, and the MRL EU ratification is the culmination of almost a decade of research and development.
Trond Williksen, chief executive, added: “The ratification of the MRL is a further stepping stone towards commercialisation following the announcement of our first customer agreements for CleanTreat in March.”
Benchmark’s solution addresses the sea lice challenge in a sustainable way both in terms of animal welfare and environmental impact, he said.